Compounds > sulfadoxine
Page last updated: 2024-08-22

sulfadoxine and Toxoplasmosis, Congenital

sulfadoxine has been researched along with Toxoplasmosis, Congenital in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.00)18.7374
1990's4 (20.00)18.2507
2000's9 (45.00)29.6817
2010's6 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoun, K; Ben Abdallah, R; Bouhlel, S; Bouratbine, A; Maatoug, R; Souissi, O1
Charpiat, B; Corvaisier, S; Dupont, D; Leboucher, G; Peyron, F; Teil, J; Vial, T; Wallon, M1
Chemla, C; Villena, I1
Dupont, D; Peyron, F1
Assouline, C; Ayoubi, JM; Berrebi, A; Berry, A; Bessières, MH; Cambus, JP; Cassaing, S; Fillaux, J; Magnaval, JF1
Assouline, C; Ayoubi, JM; Berrébi, A; Bessières, MH; Cassaing, S; Lathière, M; Minville, V1
Pradhan, P; Rai, SK; Sharma, A; Shrestha, RK1
Chemla, C; Dupouy, D; Jaussaud, R; Leroux, B; Millart, H; Pinon, JM; Quereux, C; Rémy, G; Simon, N; Trenque, T; Urien, S; Villena, I1
Coutty, N; Decocq, J; Delahousse, G; Detourmignies, L; Le Goueff, F; Mubiayi, N1
Binquet, C; Denis, P; Fleury, J; Garweg, JG; Kodjikian, L; Peyron, F; Wallon, M1
Chemla, C; Pinon, JM; Trenque, T; Villena, I1
Bost-Bru, C; Brenier-Pinchart, MP; Equy, V; Fricker-Hidalgo, H; Pelloux, H; Schaal, JP1
Faber, C; Garin, JP; Maisonneuve, H; Piens, MA1
Blanc, B; Boubli, L; Casta, M; Chagnon, C; Cravello, L; D'Ercole, C; Franck, J; Harle, JR; Leclaire, M1
Czarnecka-Rudnik, D; Stanek-Bazylko, F1
Pinon, JM; Quereux, C; Villena, I1
Aubert, D; Bonhomme, A; Chemla, C; Dupouy, D; Guenounou, M; Leroux, B; Pinon, JM; Pluot, M; Quereux, C; Schmit, G; Talmud, M; Trenque, T; Villena, I1
Berrebi, A; Bessières, MH; Bloom, MC; Cassaing, S; Courjault, C; Rolland, M; Roques, C; Séguéla, JP1
Aubert, D; Chemla, C; Dupouy, D; Leroux, B; Pinon, JM; Villena, I1
Ambroise-Thomas, P; Bost-Bru, C; Brenier-Pinchart, MP; Fricker-Hidalgo, H; Jouk, PS; Pelloux, H; Pons, JC1

Reviews

1 review(s) available for sulfadoxine and Toxoplasmosis, Congenital

ArticleYear
[Congenital toxoplasmosis: prevention in the pregnant woman and management of the neonate].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2002, Volume: 9, Issue:2

    Topics: Adult; Age Factors; Anti-Bacterial Agents; Anti-Infective Agents; Antiprotozoal Agents; Child; Coccidiostats; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Spiramycin; Sulfadiazine; Sulfadoxine; Toxoplasmosis; Toxoplasmosis, Congenital

2002

Trials

1 trial(s) available for sulfadoxine and Toxoplasmosis, Congenital

ArticleYear
[Clinical view of toxoplasmosis in children--personal observations].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 1997, Volume: 2, Issue:11

    Topics: Adolescent; Anti-Infective Agents; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Follow-Up Studies; Humans; Infant; Infant, Newborn; Mass Screening; Pyrimethamine; Serologic Tests; Spiramycin; Sulfadoxine; Toxoplasmosis; Toxoplasmosis, Congenital; Trimethoprim, Sulfamethoxazole Drug Combination

1997

Other Studies

18 other study(ies) available for sulfadoxine and Toxoplasmosis, Congenital

ArticleYear
[Management of Toxoplasmic Seroconversion in the Third Trimester of Pregnancy in Tunisia].
    Bulletin de la Societe de pathologie exotique (1990), 2018, Volume: 111, Issue:5

    Topics: Adult; Drug Combinations; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Prenatal Diagnosis; Pyrimethamine; Seroconversion; Sulfadoxine; Toxoplasmosis; Toxoplasmosis, Congenital; Tunisia; Young Adult

2018
Treatment of Congenital Toxoplasmosis: Safety of the Sulfadoxine-Pyrimethamine Combination in Children Based on a Method of Causality Assessment.
    The Pediatric infectious disease journal, 2016, Volume: 35, Issue:6

    Topics: Antimalarials; Causality; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Pregnancy; Pyrimethamine; Retrospective Studies; Sulfadoxine; Toxoplasmosis, Congenital

2016
Sulfadoxine-Pyrimethamine Combination in Congenital Toxoplasmosis.
    The Pediatric infectious disease journal, 2017, Volume: 36, Issue:3

    Topics: Antimalarials; Drug Combinations; Drug Therapy, Combination; Humans; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital

2017
In Reply: Sulfadoxine-Pyrimethamine Combination in Congenital Toxoplasmosis.
    The Pediatric infectious disease journal, 2017, Volume: 36, Issue:3

    Topics: Antimalarials; Drug Combinations; Drug Therapy, Combination; Humans; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital

2017
Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis.
    Memorias do Instituto Oswaldo Cruz, 2009, Volume: 104, Issue:2

    Topics: Amniocentesis; Animals; Antibodies, Protozoan; DNA, Protozoan; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; France; Hospitals, University; Humans; Immunoglobulin A; Immunoglobulin G; Incidence; Infant, Newborn; Polymerase Chain Reaction; Predictive Value of Tests; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Diagnosis; Pyrimethamine; Sensitivity and Specificity; Spiramycin; Sulfadoxine; Toxoplasma; Toxoplasmosis, Congenital

2009
Long-term outcome of children with congenital toxoplasmosis.
    American journal of obstetrics and gynecology, 2010, Volume: 203, Issue:6

    Topics: Age Factors; Child; Child Development; Child, Preschool; Chorioretinitis; Cohort Studies; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Monitoring, Physiologic; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Pyrimethamine; Risk Assessment; Spiramycin; Sulfadoxine; Time Factors; Toxoplasmosis, Congenital; Toxoplasmosis, Ocular

2010
First case of congenital toxoplasmosis from Nepal.
    Nepal Medical College journal : NMCJ, 2011, Volume: 13, Issue:1

    Topics: Antimalarials; Antiprotozoal Agents; Drug Combinations; Fatal Outcome; Humans; Infant; Male; Nepal; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital

2011
Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis.
    British journal of clinical pharmacology, 2004, Volume: 57, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Male; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital

2004
[Maternal pancytopenia during antenatal treatment of congenital toxoplasmosis].
    Presse medicale (Paris, France : 1983), 2004, Aug-28, Volume: 33, Issue:14 Pt 1

    Topics: Adult; Antiprotozoal Agents; Drug Therapy, Combination; Female; Humans; Pancytopenia; Parity; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Pyrimethamine; Sulfadiazine; Sulfadoxine; Toxoplasmosis, Congenital

2004
Ocular manifestations in congenital toxoplasmosis.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2006, Volume: 244, Issue:1

    Topics: Adolescent; Adult; Antibodies, Protozoan; Antiprotozoal Agents; Child; Child, Preschool; Chorioretinitis; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Male; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital; Toxoplasmosis, Ocular; Vision Disorders

2006
[Prenatal treatment of congenital toxoplasmosis].
    Presse medicale (Paris, France : 1983), 2005, Dec-17, Volume: 34, Issue:22 Pt 1

    Topics: Antimalarials; Drug Combinations; Female; Follow-Up Studies; Humans; Leucovorin; Neutropenia; Pregnancy; Prenatal Care; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital; Vitamin B Complex

2005
Value of Toxoplasma gondii detection in one hundred thirty-three placentas for the diagnosis of congenital toxoplasmosis.
    The Pediatric infectious disease journal, 2007, Volume: 26, Issue:9

    Topics: Animals; Anti-Infective Agents; Child, Preschool; Female; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Mice; Placenta; Polymerase Chain Reaction; Pregnancy; Pyrimethamine; Sensitivity and Specificity; Spiramycin; Sulfadoxine; Toxoplasma; Toxoplasmosis, Congenital

2007
[Congenital toxoplasmosis. Tolerability of the sulfadoxine-pyrimethamine combination. 24 cases].
    Presse medicale (Paris, France : 1983), 1984, Mar-31, Volume: 13, Issue:14

    Topics: Child, Preschool; Drug Combinations; Female; Humans; Infant; Leucovorin; Male; Pyrimethamine; Sulfadoxine; Sulfanilamides; Toxoplasmosis, Congenital

1984
Recurrent congenital toxoplasmosis in a woman with lupus erythematosus.
    Prenatal diagnosis, 1995, Volume: 15, Issue:12

    Topics: Adult; Amniotic Fluid; Animals; Anti-Infective Agents; Antibodies, Protozoan; Female; Fetal Diseases; Humans; Immunoglobulin G; Immunoglobulin M; Infant, Newborn; Lupus Erythematosus, Systemic; Prednisolone; Pregnancy; Pregnancy Complications; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Toxoplasma; Toxoplasmosis, Congenital

1995
Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination.
    Prenatal diagnosis, 1998, Volume: 18, Issue:7

    Topics: Anti-Infective Agents; Antiprotozoal Agents; Female; Fetal Diseases; Humans; Pregnancy; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital

1998
Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group.
    Scandinavian journal of infectious diseases, 1998, Volume: 30, Issue:3

    Topics: Adolescent; Antimalarials; Child; Child, Preschool; Chorioretinitis; Drug Administration Schedule; Drug Combinations; Follow-Up Studies; Humans; Infant; Infant, Newborn; Leucovorin; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital

1998
Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests.
    European journal of obstetrics, gynecology, and reproductive biology, 2001, Volume: 94, Issue:1

    Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Cohort Studies; Female; Fetal Blood; Fetal Diseases; Humans; Immunoglobulin A; Immunoglobulin M; Infant, Newborn; Neonatal Screening; Placenta; Pregnancy; Pregnancy Complications, Infectious; Prenatal Diagnosis; Pyrimethamine; Spiramycin; Sulfadoxine; Toxoplasma; Toxoplasmosis, Congenital

2001
[Frequency of persistent or transitory serologic negative values in infants with congenital toxoplasmosis. Experience of the Reims Toxoplasmosis Group (1980-1997)].
    Presse medicale (Paris, France : 1983), 2002, Feb-09, Volume: 31, Issue:5

    Topics: Animals; Antibodies, Protozoan; Drug Combinations; Follow-Up Studies; Humans; Infant; Infant, Newborn; Pyrimethamine; Spiramycin; Sulfadoxine; Toxoplasma; Toxoplasmosis, Congenital

2002